Endogenous adenine as a key player in diabetic kidney disease progression: an integrated multiomics approach

Kidney Int. 2024 May;105(5):918-920. doi: 10.1016/j.kint.2023.11.033.

Authors

Yu Ah Hong¹, Masaomi Nangaku²

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Jung-gu, Daejeon, Republic of Korea; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. Electronic address: amorfati@catholic.ac.kr.
² Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

PMID: 38642987
DOI: 10.1016/j.kint.2023.11.033

No abstract available

Keywords: adenine; biomarker; diabetic kidney disease; mTOR; multiomics.

MeSH terms

Adenine
Diabetes Mellitus*
Diabetic Nephropathies* / etiology
Disease Progression
Humans
Kidney
Multiomics
Renal Insufficiency, Chronic*

Substances

Adenine